Next Story
Newszop

High Gleason Score: Understanding signs and managing symptoms of Prostate cancer

Send Push
Prostate cancer remains among the most prevalent cancers in men whose prognosis and treatment is overwhelmingly dependent on the Gleason scoring system. The recent diagnosis of former United States President Joe Biden with an aggressive form of prostate cancer underscores the exceedingly important role played by the grading system in daily practice.

Understanding the Gleason Score

The Gleason score is the histopathologic grading system for assessing the architectural patterns of prostate cancer cells in biopsies. The scores range from 6 to 10, and higher values indicate more virulent and poorly differentiated tumors. A Gleason score of 9, for instance, as in President Biden's case, is a high-grade cancer with high potential for progression and metastasis.

Clinical Significance of a High Gleason Score

A Gleason score of 9 places the cancer in Grade Group 5, which is the highest group. High-grade tumors are more likely to grow beyond the capsule, invade the seminal vesicles, and spread distantly to bones. In Biden's situation, the cancer is also spread to the bone, so an advanced cancer.
Regular screening by clinical examination and PSA is the most important in early detection of prostate cancer . Routine health check up is advised in men over 60 years of age.

Treatment Considerations

Although high Gleason score prostate cancers are advanced, there are several treatment options. Androgen deprivation therapy (ADT) can be used to treat hormone-sensitive tumors like Biden's by reducing testosterone levels to retard the cancer. Other therapy may involve chemotherapy and radiation treatment, depending on the patient's overall health and the rate at which the cancer is progressing.



The Role of Early Detection

Biden's diagnosis highlights the challenges of early identification of dangerous prostate cancer. While routine screening using prostate-specific antigen (PSA) tests can identify issues, their sensitivity to finding high-grade cancers is uncertain. Furthermore, the benefits of mass screening with PSA are questionable due to the problem of overdiagnosis and overtreatment.

Enhancement of Diagnostic Equipment

Technologies such as multiparametric MRI, PSMA PET scans and AI-based pathology are also enhancing the accuracy of prostate cancer detection and Gleason scoring.
These technologies can identify suspicious areas with greater accuracy and reduce interobserver variation in grading, which will allow more accurate treatment planning.


Conclusion

The Gleason score remains a standard in the diagnosis and treatment of prostate cancer. President Biden's recent diagnosis with an aggressive Gleason score cancer points up the utility of this grading system in choosing treatment. As diagnostic technology improves, it holds the promise of enhancing early detection and personalized care for patients facing this challenging disease.

(Article Courtesy: Dr Mangesh Patil, Head Minimal Invasive Urology and Endourology - Renal Sciences, Sir HN Reliance Foundation Hospital. Mumbai)


Loving Newspoint? Download the app now